219 related articles for article (PubMed ID: 21211028)
1. Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.
Roth C; Pantel K; Müller V; Rack B; Kasimir-Bauer S; Janni W; Schwarzenbach H
BMC Cancer; 2011 Jan; 11():4. PubMed ID: 21211028
[TBL] [Abstract][Full Text] [Related]
2. Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients.
Wimberger P; Roth C; Pantel K; Kasimir-Bauer S; Kimmig R; Schwarzenbach H
Int J Cancer; 2011 Jun; 128(11):2572-80. PubMed ID: 20715113
[TBL] [Abstract][Full Text] [Related]
3. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer.
Roth C; Kasimir-Bauer S; Pantel K; Schwarzenbach H
Mol Oncol; 2011 Jun; 5(3):281-91. PubMed ID: 21398193
[TBL] [Abstract][Full Text] [Related]
4. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
[TBL] [Abstract][Full Text] [Related]
5. Protease Activity and Cell-Free DNA in Blood Plasma of Healthy Donors and Breast Cancer Patients.
Tamkovich S; Bryzgunova O
J Immunoassay Immunochem; 2016; 37(2):141-53. PubMed ID: 26264080
[TBL] [Abstract][Full Text] [Related]
6. Circulating nucleic acids and protease activities in blood of tumor patients.
Schwarzenbach H
Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S163-9. PubMed ID: 22506790
[TBL] [Abstract][Full Text] [Related]
7. Parallel assessment of circulatory cell-free DNA by PCR and nucleosomes by ELISA in breast tumors.
Seefeld M; El Tarhouny S; Fan AX; Hahn S; Holzgreve W; Zhong XY
Int J Biol Markers; 2008; 23(2):69-73. PubMed ID: 18629778
[TBL] [Abstract][Full Text] [Related]
8. Levels of circulating cell-free serum DNA in benign and malignant breast lesions.
Zanetti-Dällenbach RA; Schmid S; Wight E; Holzgreve W; Ladewing A; Hahn S; Zhong XY
Int J Biol Markers; 2007; 22(2):95-9. PubMed ID: 17549664
[TBL] [Abstract][Full Text] [Related]
9. Circulating nucleic acids as biomarkers in breast cancer.
Schwarzenbach H
Breast Cancer Res; 2013; 15(5):211. PubMed ID: 24090167
[TBL] [Abstract][Full Text] [Related]
10. Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma.
Deligezer U; Erten N; Akisik EE; Dalay N
Exp Mol Pathol; 2006 Feb; 80(1):72-6. PubMed ID: 15961076
[TBL] [Abstract][Full Text] [Related]
11. Differential levels of soluble intercellular adhesion molecule-1 (sICAM-1) in early breast cancer and benign breast lesions.
Altomonte M; Fonsatti E; Lamaj E; Cattarossi I; Cattelan A; Maio M
Breast Cancer Res Treat; 1999 Nov; 58(1):19-23. PubMed ID: 10634514
[TBL] [Abstract][Full Text] [Related]
12. Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.
Arko-Boham B; Aryee NA; Blay RM; Owusu EDA; Tagoe EA; Doris Shackie ES; Debrah AB; Adu-Aryee NA
Cancer Genet; 2019 Jun; 235-236():65-71. PubMed ID: 31105051
[TBL] [Abstract][Full Text] [Related]
13. Nucleosomes in serum of patients with benign and malignant diseases.
Holdenrieder S; Stieber P; Bodenmüller H; Busch M; Fertig G; Fürst H; Schalhorn A; Schmeller N; Untch M; Seidel D
Int J Cancer; 2001 Mar; 95(2):114-20. PubMed ID: 11241322
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor.
El Tarhouny S; Seefeld M; Fan AX; Hahn S; Holzgreve W; Zhong XY
Cytokine; 2008 Oct; 44(1):65-9. PubMed ID: 18691902
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
[TBL] [Abstract][Full Text] [Related]
16. Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.
Matuschek C; Bölke E; Lammering G; Gerber PA; Peiper M; Budach W; Taskin H; Prisack HB; Schieren G; Orth K; Bojar H
Eur J Med Res; 2010; 15(7):277-86. PubMed ID: 20696638
[TBL] [Abstract][Full Text] [Related]
17. A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer.
Schwarzenbach H; Müller V; Beeger C; Gottberg M; Stahmann N; Pantel K
Breast Cancer Res; 2007; 9(5):R66. PubMed ID: 17915011
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of plasma nucleosome levels in cancer patients.
Kuroi K; Tanaka C; Toi M
Int J Oncol; 2001 Jul; 19(1):143-8. PubMed ID: 11408935
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer.
Schwarzenbach H; Pantel K; Kemper B; Beeger C; Otterbach F; Kimmig R; Kasimir-Bauer S
Breast Cancer Res; 2009; 11(5):R71. PubMed ID: 19772563
[TBL] [Abstract][Full Text] [Related]
20. Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor-derived extracellular vesicles.
Chennakrishnaiah S; Meehan B; D'Asti E; Montermini L; Lee TH; Karatzas N; Buchanan M; Tawil N; Choi D; Divangahi M; Basik M; Rak J
J Thromb Haemost; 2018 Sep; 16(9):1800-1813. PubMed ID: 29971917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
